Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027
The global nanomedicine market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242655.19 million by 2027. The market is driven by the factors such as the growing healthcare expenditure and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications. Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the global nanomedicine market in the forecast period.
Nanomedicines are considered very effective in treating chronic diseases such as cancer, dementia, and diabetes as they fuel the metabolism of medications in the body. They deliver the drugs at the target site in the right proportion. The market's availability of nanomedical products such as DNA probes, nanosensors, and nanoparticle-based imaging agents is increasing the demand. However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the global nanomedicine market in the forecast period.
The global nanomedicine market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape. Based on application, the nanomedicine market is divided into drug delivery, vaccines, diagnostic imaging, regenerative medicine, and others. Drug delivery applications dominated the market in 2021 and captured 30.23% of the overall market share. This segment is expected to maintain its dominance over the next five years. The rise in awareness about the benefits of nanomedicine in drug delivery applications and the increased prevalence of diseases drives the demand for nanomedicines for drug delivery applications.
The major market players operating in the global nanomedicine market are Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S, Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd., among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth and the market size of the global nanomedicine market from 2017 to 2021.
- To estimate and forecast the market size of the global nanomedicine market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the global nanomedicine market is divided into nanomolecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.
- To identify drivers and challenges for the global nanomedicine market.
- To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global nanomedicine market.
- To conduct pricing analysis for the global nanomedicine market.
- To identify and analyze the profile of leading players operating in global nanomedicine market.
TechSci Research calculated the global nanomedicine market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Nanomedicine manufacturers/ suppliers/ distributors
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to nanomedicine
- Market research and consulting firms
Report Scope:
In this report, global nanomedicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Nanomedicine Market, By Nanomolecule Type:
- Nanoparticles
- Nanoshells
- Nanodevices
- Nanotubes
- Nanomedicine Market, By Nanoparticles Type:
- Polymer-based
- Lipid-based
- Nanocrystals
- Inorganic
- Others
- Nanomedicine Market, By Application:
- Drug Delivery
- Vaccines
- Diagnostic Imaging
- Regenerative Medicine
- Others
- Nanomedicine Market, By Disease Indication:
- Oncological Diseases
- Infectious Diseases
- Orthopedic Disorders
- Cardiovascular Diseases
- Others
- Nanomedicine Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Denmark
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Vietnam
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Israel
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Company Profiles: Detailed analysis of the major companies present in global nanomedicine market.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Nanomedicine Market
- 5. Voice of Customer
- 5.1. Factors Increasing the demand for Nanomedicine
- 5.2. Preference, By Nanomolecule Type
- 5.3. Demand for Nanomedicine, By Indication
- 5.4. Brand Awareness
- 6. Global Nanomedicine Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 6.2.4. By Company (2021)
- 6.2.5. By Region
- 6.3. Market Map
- 7. North America Nanomedicine Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 7.2.4. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Nanomedicine Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Nanomolecule Type
- 7.3.1.2.1.1. By Nanoparticle Type
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By Disease Indication
- 7.3.2. Canada Nanomedicine Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Nanomolecule Type
- 7.3.2.2.1.1. By Nanoparticle Type
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By Disease Indication
- 7.3.3. Mexico Nanomedicine Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Nanomolecule Type
- 7.3.3.2.1.1. By Nanoparticle Type
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By Disease Indication
- 8. Europe Nanomedicine Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 8.2.4. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. Germany Nanomedicine Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Nanomolecule Type
- 8.3.1.2.1.1. By Nanoparticle Type
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By Disease Indication
- 8.3.2. France Nanomedicine Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Nanomolecule Type
- 8.3.2.2.1.1. By Nanoparticle Type
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By Disease Indication
- 8.3.3. United Kingdom Nanomedicine Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Nanomolecule Type
- 8.3.3.2.1.1. By Nanoparticle Type
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By Disease Indication
- 8.3.4. Italy Nanomedicine Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Nanomolecule Type
- 8.3.4.2.1.1. By Nanoparticle Type
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By Disease Indication
- 8.3.5. Spain Nanomedicine Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Nanomolecule Type
- 8.3.5.2.1.1. By Nanoparticle Type
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By Disease Indication
- 8.3.6. Denmark Nanomedicine Market Outlook
- 8.3.6.1. Market Size & Forecast
- 8.3.6.1.1. By Value
- 8.3.6.2. Market Share & Forecast
- 8.3.6.2.1. By Nanomolecule Type
- 8.3.6.2.1.1. By Nanoparticle Type
- 8.3.6.2.2. By Application
- 8.3.6.2.3. By Disease Indication
- 9. Asia Pacific Nanomedicine Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 9.2.4. By Country
- 9.3. Asia Pacific: Country Analysis
- 9.3.1. China Nanomedicine Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Nanomolecule Type
- 9.3.1.2.1.1. By Nanoparticle Type
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By Disease Indication
- 9.3.2. Japan Nanomedicine Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Nanomolecule Type
- 9.3.2.2.1.1. By Nanoparticle Type
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By Disease Indication
- 9.3.3. India Nanomedicine Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Nanomolecule Type
- 9.3.3.2.1.1. By Nanoparticle Type
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By Disease Indication
- 9.3.4. Australia Nanomedicine Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Nanomolecule Type
- 9.3.4.2.1.1. By Nanoparticle Type
- 9.3.4.2.2. By Application
- 9.3.4.2.3. By Disease Indication
- 9.3.5. South Korea Nanomedicine Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Nanomolecule Type
- 9.3.5.2.1.1. By Nanoparticle Type
- 9.3.5.2.2. By Application
- 9.3.5.2.3. By Disease Indication
- 9.3.6. Malaysia Nanomedicine Market Outlook
- 9.3.6.1. Market Size & Forecast
- 9.3.6.1.1. By Value
- 9.3.6.2. Market Share & Forecast
- 9.3.6.2.1. By Nanomolecule Type
- 9.3.6.2.1.1. By Nanoparticle Type
- 9.3.6.2.2. By Application
- 9.3.6.2.3. By Disease Indication
- 9.3.7. Vietnam Nanomedicine Market Outlook
- 9.3.7.1. Market Size & Forecast
- 9.3.7.1.1. By Value
- 9.3.7.2. Market Share & Forecast
- 9.3.7.2.1. By Nanomolecule Type
- 9.3.7.2.1.1. By Nanoparticle Type
- 9.3.7.2.2. By Application
- 9.3.7.2.3. By Disease Indication
- 10. South America Nanomedicine Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 10.2.4. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Nanomedicine Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Nanomolecule Type
- 10.3.1.2.1.1. By Nanoparticle Type
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By Disease Indication
- 10.3.2. Argentina Nanomedicine Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Nanomolecule Type
- 10.3.2.2.1.1. By Nanoparticle Type
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By Disease Indication
- 10.3.3. Colombia Nanomedicine Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Nanomolecule Type
- 10.3.3.2.1.1. By Nanoparticle Type
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By Disease Indication
- 11. Middle East and Africa Nanomedicine Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid – based, Nanocrystals, Inorganic, Others)
- 11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 11.2.4. By Country
- 11.3. Middle East and Africa: Country Analysis
- 11.3.1. Turkey Nanomedicine Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Nanomolecule Type
- 11.3.1.2.1.1. By Nanoparticle Type
- 11.3.1.2.2. By Application
- 11.3.1.2.3. By Disease Indication
- 11.3.2. Israel Nanomedicine Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Nanomolecule Type
- 11.3.2.2.1.1. By Nanoparticle Type
- 11.3.2.2.2. By Application
- 11.3.2.2.3. By Disease Indication
- 11.3.3. South Africa Nanomedicine Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Nanomolecule Type
- 11.3.3.2.1.1. By Nanoparticle Type
- 11.3.3.2.2. By Application
- 11.3.3.2.3. By Disease Indication
- 11.3.4. Saudi Arabia Nanomedicine Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Nanomolecule Type
- 11.3.4.2.1.1. By Nanoparticle Type
- 11.3.4.2.2. By Application
- 11.3.4.2.3. By Disease Indication
- 11.3.5. UAE Nanomedicine Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Nanomolecule Type
- 11.3.5.2.1.1. By Nanoparticle Type
- 11.3.5.2.2. By Application
- 11.3.5.2.3. By Disease Indication
- 11.3.6. Kuwait Nanomedicine Market Outlook
- 11.3.6.1. Market Size & Forecast
- 11.3.6.1.1. By Value
- 11.3.6.2. Market Share & Forecast
- 11.3.6.2.1. By Nanomolecule Type
- 11.3.6.2.1.1. By Nanoparticle Type
- 11.3.6.2.2. By Application
- 11.3.6.2.3. By Disease Indication
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends and Developments
- 14. Competitive Landscape
- 14.1. Pfizer Inc.
- 14.2. Janssen Pharmaceuticals
- 14.3. Sanofi S.A.
- 14.4. Amgen Inc.
- 14.5. Moderna, Inc.
- 14.6. Novo Nordisk A/S
- 14.7. Genentech, Inc
- 14.8. Celgene Corporation
- 14.9. Vifor Pharma Ltd.
- 14.10. Teva Pharmaceutical Industries Ltd.
- 15. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook